These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8247394

  • 1. Trends in the management of childhood lead poisonings.
    Rosen JF, Markowitz ME.
    Neurotoxicology; 1993; 14(2-3):211-7. PubMed ID: 8247394
    [Abstract] [Full Text] [Related]

  • 2. Effects of calcium disodium versenate (CaNa2EDTA) chelation in moderate childhood lead poisoning.
    Markowitz ME, Bijur PE, Ruff H, Rosen JF.
    Pediatrics; 1993 Aug; 92(2):265-71. PubMed ID: 8337028
    [Abstract] [Full Text] [Related]

  • 3. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
    Tantanasrikul S, Chaivisuth B, Siriratanapreuk S, Padungtod C, Pleubreukan R, Boonnark T, Worahan S, Bhumiratanarak P, Chomchai C.
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
    [Abstract] [Full Text] [Related]

  • 4. Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.
    Rosen JF, Markowitz ME, Bijur PE, Jenks ST, Wielopolski L, Kalef-Ezra JA, Slatkin DN.
    Environ Health Perspect; 1991 Jun; 93():271-7. PubMed ID: 1773798
    [Abstract] [Full Text] [Related]

  • 5. Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.
    Rosen JF, Markowitz ME, Bijur PE, Jenks ST, Wielopolski L, Kalef-Ezra JA, Slatkin DN.
    Environ Health Perspect; 1991 Feb; 91():57-62. PubMed ID: 1904023
    [Abstract] [Full Text] [Related]

  • 6. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB, Anderson RL, Super DM.
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [Abstract] [Full Text] [Related]

  • 7. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
    Yu GY, Yan CH, Yu XG, Zuo Y, Zou XY, Xu J, Wu SH, Shen XM.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
    [Abstract] [Full Text] [Related]

  • 8. Effects of chelation therapy on hepatic glutathione, lipid peroxidation and phospholipid contents in lead-poisoned rats.
    Sachan AS, Kannan GM, Kumar P, Flora SJ.
    Indian J Physiol Pharmacol; 1996 Apr; 40(2):180-2. PubMed ID: 9062817
    [Abstract] [Full Text] [Related]

  • 9. Management of childhood lead poisoning: a survey.
    Glotzer DE, Bauchner H.
    Pediatrics; 1992 Apr; 89(4 Pt 1):614-8. PubMed ID: 1313555
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD, Luck ML, Laughlin NK, Smith DR.
    Toxicol Appl Pharmacol; 1999 Dec 15; 161(3):283-93. PubMed ID: 10620486
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D, Bayer L, Strupp BJ.
    Environ Res; 1998 Aug 15; 78(2):168-76. PubMed ID: 9719621
    [Abstract] [Full Text] [Related]

  • 12. Lightening the lead load in children.
    Ellis MR, Kane KY.
    Am Fam Physician; 2000 Aug 01; 62(3):545-54, 559-60. PubMed ID: 10950212
    [Abstract] [Full Text] [Related]

  • 13. Infantile lead poisoning from an Asian tongue powder: a case report & subsequent public health inquiry.
    Woolf AD, Hussain J, McCullough L, Petranovic M, Chomchai C.
    Clin Toxicol (Phila); 2008 Nov 01; 46(9):841-4. PubMed ID: 18608276
    [Abstract] [Full Text] [Related]

  • 14. Arsenic and lead induced free radical generation and their reversibility following chelation.
    Flora SJ, Flora G, Saxena G, Mishra M.
    Cell Mol Biol (Noisy-le-grand); 2007 Apr 15; 53(1):26-47. PubMed ID: 17519110
    [Abstract] [Full Text] [Related]

  • 15. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ, Pande M, Kannan GM, Mehta A.
    Cell Mol Biol (Noisy-le-grand); 2004 Apr 15; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [Abstract] [Full Text] [Related]

  • 16. Successful treatment of extreme acute lead intoxication.
    Mikler J, Banovcin P, Jesenak M, Hamzikova J, Statelova D.
    Toxicol Ind Health; 2009 Mar 15; 25(2):137-40. PubMed ID: 19458136
    [Abstract] [Full Text] [Related]

  • 17. Succimer and the reduction of tissue lead in juvenile monkeys.
    Smith DR, Woolard D, Luck ML, Laughlin NK.
    Toxicol Appl Pharmacol; 2000 Aug 01; 166(3):230-40. PubMed ID: 10906287
    [Abstract] [Full Text] [Related]

  • 18. Effect of succimer chelation therapy on postural balance and gait outcomes in children with early exposure to environmental lead.
    Bhattacharya A, Shukla R, Auyang ED, Dietrich KN, Bornschein R.
    Neurotoxicology; 2007 May 01; 28(3):686-95. PubMed ID: 17499360
    [Abstract] [Full Text] [Related]

  • 19. Chelation therapy to treat lead toxicity in children.
    Wegmann K.
    Minn Med; 1992 Nov 01; 75(11):25-7. PubMed ID: 1331737
    [Abstract] [Full Text] [Related]

  • 20. Succimer, an oral lead chelator.
    Mann KV, Travers JD.
    Clin Pharm; 1991 Dec 01; 10(12):914-22. PubMed ID: 1663439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.